Header cover image

Danish (OMX) Healthcare Sector Analysis

UpdatedFeb 17, 2025
DataAggregated Company Financials
Companies21
  • 7D-9.2%
  • 3M-18.1%
  • 1Y-30.5%
  • YTD-10.5%

Over the last 7 days, the Healthcare industry has dropped 9.2%, driven by Novo Nordisk declining 11%. In contrast, Genmab has gained 8.6%. However, the industry is down 31% over the past year. Earnings are forecast to grow by 13% annually.

Sector Valuation and Performance

Has the Danish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 17 Feb 2025DKK 3.0tDKK 409.9bDKK 121.5b26.3x24.9x7.4x
Wed, 15 Jan 2025DKK 3.2tDKK 387.5bDKK 111.3b28.9x28.6x8.2x
Fri, 13 Dec 2024DKK 4.0tDKK 387.4bDKK 111.3b30.8x36.1x10.4x
Sun, 10 Nov 2024DKK 3.9tDKK 386.3bDKK 110.7b32.7x35.1x10.1x
Tue, 08 Oct 2024DKK 4.1tDKK 372.0bDKK 107.1b36.3x38.6x11.1x
Thu, 05 Sep 2024DKK 4.6tDKK 371.9bDKK 107.2b35.3x43.2x12.4x
Sat, 03 Aug 2024DKK 4.5tDKK 355.3bDKK 106.3b36.6x42x12.6x
Mon, 01 Jul 2024DKK 5.0tDKK 355.3bDKK 106.2b35.1x47.4x14.2x
Wed, 29 May 2024DKK 4.6tDKK 355.3bDKK 106.2b37.2x43.6x13x
Fri, 26 Apr 2024DKK 4.4tDKK 341.4bDKK 99.6b32.8x44.3x12.9x
Sun, 24 Mar 2024DKK 4.6tDKK 341.2bDKK 99.6b39.7x45.7x13.4x
Tue, 20 Feb 2024DKK 4.4tDKK 340.0bDKK 98.7b34.9x44.7x13x
Thu, 18 Jan 2024DKK 3.8tDKK 320.5bDKK 90.0b33.5x42.1x11.8x
Sat, 16 Dec 2023DKK 3.5tDKK 320.5bDKK 90.0b32.9x38.7x10.9x
Mon, 13 Nov 2023DKK 3.6tDKK 319.8bDKK 89.9b31.7x39.6x11.1x
Wed, 11 Oct 2023DKK 3.4tDKK 305.5bDKK 82.2b34.2x41.7x11.2x
Fri, 08 Sep 2023DKK 3.6tDKK 305.5bDKK 82.2b36.3x43.3x11.6x
Sun, 06 Aug 2023DKK 2.9tDKK 288.2bDKK 74.9b38.5x38.6x10x
Tue, 04 Jul 2023DKK 3.0tDKK 287.1bDKK 75.5b39.7x39.3x10.3x
Thu, 01 Jun 2023DKK 3.1tDKK 287.2bDKK 75.5b41x40.6x10.7x
Sat, 29 Apr 2023DKK 3.1tDKK 272.6bDKK 69.0b44.7x45.1x11.4x
Mon, 27 Mar 2023DKK 2.9tDKK 291.2bDKK 69.0b36.7x42.1x10x
Wed, 22 Feb 2023DKK 2.8tDKK 289.4bDKK 68.9b40.5x40.8x9.7x
Fri, 20 Jan 2023DKK 2.7tDKK 276.0bDKK 66.3b38.4x41x9.8x
Sun, 18 Dec 2022DKK 2.7tDKK 276.1bDKK 66.3b37.7x40x9.6x
Tue, 15 Nov 2022DKK 2.5tDKK 276.0bDKK 66.4b36.1x37x8.9x
Thu, 13 Oct 2022DKK 2.3tDKK 261.4bDKK 62.4b33.7x37.4x8.9x
Sat, 10 Sep 2022DKK 2.4tDKK 261.1bDKK 62.4b35.8x38.4x9.2x
Mon, 08 Aug 2022DKK 2.3tDKK 256.0bDKK 61.1b33.9x37.6x9x
Wed, 06 Jul 2022DKK 2.4tDKK 247.8bDKK 59.9b36.5x39.4x9.5x
Fri, 03 Jun 2022DKK 2.3tDKK 247.6bDKK 59.7b35.4x38.4x9.3x
Sun, 01 May 2022DKK 2.4tDKK 238.2bDKK 59.8b38.1x40.6x10.2x
Tue, 29 Mar 2022DKK 2.3tDKK 238.0bDKK 59.8b39.8x37.9x9.5x
Thu, 24 Feb 2022DKK 2.1tDKK 237.5bDKK 59.4b37.7x34.6x8.7x
Price to Earnings Ratio

34.6x


Total Market Cap: DKK 2.1tTotal Earnings: DKK 59.4bTotal Revenue: DKK 237.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Healthcare Sector Price to Earnings3Y Average 40x202320242025
Current Industry PE
  • Investors are pessimistic on the Danish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 24.9x which is lower than its 3-year average PE of 40.0x.
  • The 3-year average PS ratio of 10.7x is higher than the industry's current PS ratio of 7.4x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 27% per year over the last three years.
  • Revenues for these companies have grown 20% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare sector?

DK Market-5.41%
Healthcare-9.18%
Biotech6.52%
Life Sciences3.54%
Medical Equipment0.99%
Healthcare Services-4.53%
Healthtech-8.41%
Pharma-11.12%
Industry PE
  • Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 98.8x.
    • Analysts expect its future annual earnings growth (17.0%) to be largely in line with prior year's earnings growth.
  • Investors are most pessimistic about the Healthcare Services industry, which is trading close to its 3-year average of 21.0x.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 51% over the next 5 years.
  • In contrast, the Pharma industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GMAB GenmabDKK 1.51k10.4%
+DKK 9.0b
-25.8%PE12.2x
ZEAL Zealand PharmaDKK 772.007.8%
+DKK 4.0b
60.3%PS709.5x
COLO B ColoplastDKK 793.801.3%
+DKK 2.3b
-10.3%PE36.6x
AMBU B AmbuDKK 139.003.8%
+DKK 1.4b
14.9%PE113.6x
GUBRA GubraDKK 672.006.7%
+DKK 684.9m
330.8%PS49x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BAVA

DKK 174.90

Bavarian Nordic

7D

0.8%

1Y

4.3%

COLO B

DKK 793.80

Coloplast

7D

1.3%

1Y

-10.3%

GUBRA

DKK 672.00

Gubra

7D

6.7%

1Y

330.8%

ALK B

DKK 153.90

ALK-Abelló

7D

-3.6%

1Y

19.8%

VIRO

DKK 10.90

ViroGates

7D

-12.1%

1Y

31.0%

MONSO

DKK 0.23

Monsenso

7D

-14.1%

1Y

-23.7%